Skip to main content
padlock icon - secure page this page is secure

Aeroallergen sensitization in asthma: Prevalence and correlation with severity

Buy Article:

$36.50 + tax (Refund Policy)

Aeroallergen sensitization occurs in most patients with asthma and is noted in a high percentage of patients with mild and moderate asthma. The percentage of those that are atopic with severe asthma appears less, but still approximates the percent seen in patients with mild and moderate asthma. The objective of this study was to review the prevalence of positive skin tests and atopic disease in patients with asthma. A review was performed of the literature with searches to include “skin test and asthma,” “allergic asthma,” and “allergies and asthma” in both PubMed and Ovid and selected articles that were relative to our objective. Most studies highlight the significances that allergic disease plays in asthma. However, the prevalence of allergic disease in mild to moderate asthma ranges from 50 to 95% and recent data suggest that 95% may be very accurate. In severe asthma the percentage is less, but still recent data suggest it may be as high as 90%. Patients with high IgE, high exhaled nitric oxide (eNO), low provocative concentration of methacholine causing a 20% fall in forced expiratory ventilation in 1 second (PC20) and minority ethnicity have a higher number of positive skin tests and presumably are hypersensitive to more aeroallergens. Patients with late-onset asthma are less likely to be allergic; nonetheless, the vast majority even >65 years of age have an allergic component to their disease. Female gender, late-onset asthma, nasal polyps, severe asthma, and, possibly, patients with a reaction to autologous serum injection increases the likelihood that asthma may be nonallergic, as defined by negative skin tests. The vast majority of patients with mild-to-moderate and even severe asthma have an allergic component to their disease. Avoidance, omalizumab, and allergen immunotherapy may be useful in all severities of asthma, even in the elderly, if indicated and not contraindicated. As many as 90‐95% of patients with asthma have aeroallergen sensitization and the pattern varies with ethnicity, location of residence, and onset of asthma, but not age. Higher levels of IgE and eNO and lower values of PC20, are noted in patients with asthma and aeroallergen sensitization.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Aeroallergens; allergies; asthma; autologous skin test; hypersensitivity; mild asthma; moderate asthma; severe asthma; skin testing

Document Type: Research Article

Affiliations: Pennsylvania State University College of Medicine, Section of Allergy, Asthma, and Immunology, Hershey, Pennsylvania, USA. [email protected]

Publication date: March 1, 2010

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more